SE401674B - Forfarande for framstellning av farmakologiskt aktiva bensocykloheptaisokinolinderivat samt syraadditionssalter derav - Google Patents

Forfarande for framstellning av farmakologiskt aktiva bensocykloheptaisokinolinderivat samt syraadditionssalter derav

Info

Publication number
SE401674B
SE401674B SE7101475A SE147571A SE401674B SE 401674 B SE401674 B SE 401674B SE 7101475 A SE7101475 A SE 7101475A SE 147571 A SE147571 A SE 147571A SE 401674 B SE401674 B SE 401674B
Authority
SE
Sweden
Prior art keywords
benzocycloheptaisochinoline
derivatives
procedure
preparation
pharmacologically active
Prior art date
Application number
SE7101475A
Other languages
English (en)
Swedish (sv)
Inventor
F T Bruderlein
L G Humber
Original Assignee
Ayerst Mckenna & Harrison
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ayerst Mckenna & Harrison filed Critical Ayerst Mckenna & Harrison
Priority claimed from US510275A external-priority patent/US3922346A/en
Publication of SE401674B publication Critical patent/SE401674B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D455/00Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00Carboxylic acid amides
    • C07C233/01Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/02Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D211/74Oxygen atoms
    • C07D211/76Oxygen atoms attached in position 2 or 6
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D455/00Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/03Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/04Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing a quinolizine ring system condensed with only one six-membered carbocyclic ring, e.g. julolidine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/06Peri-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE7101475A 1970-02-10 1971-02-05 Forfarande for framstellning av farmakologiskt aktiva bensocykloheptaisokinolinderivat samt syraadditionssalter derav SE401674B (sv)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US1030670A 1970-02-10 1970-02-10
US097481A US3914305A (en) 1970-02-10 1970-12-21 N-{8 (10,11-dihydro-5H-dibenzo{8 a,d{9 cyclohepten-5-yl)methyl{9 amides
US510275A US3922346A (en) 1970-02-10 1974-09-30 Benzocycloheptaisoquinoline derivatives III in producing CNS depressant effects

Publications (1)

Publication Number Publication Date
SE401674B true SE401674B (sv) 1978-05-22

Family

ID=27359200

Family Applications (2)

Application Number Title Priority Date Filing Date
SE7101475A SE401674B (sv) 1970-02-10 1971-02-05 Forfarande for framstellning av farmakologiskt aktiva bensocykloheptaisokinolinderivat samt syraadditionssalter derav
SE7315436A SE406195B (sv) 1970-02-10 1973-11-14 Forfarande for framstellning av bensocykloheptaisokinolinderivat samt syraadditionssalter derav

Family Applications After (1)

Application Number Title Priority Date Filing Date
SE7315436A SE406195B (sv) 1970-02-10 1973-11-14 Forfarande for framstellning av bensocykloheptaisokinolinderivat samt syraadditionssalter derav

Country Status (14)

Country Link
US (2) US3657250A (nl)
AR (4) AR195768A1 (nl)
BE (1) BE762595A (nl)
CA (1) CA982124A (nl)
CH (3) CH584201A5 (nl)
CS (1) CS181207B2 (nl)
DE (1) DE2106165A1 (nl)
DK (1) DK139582B (nl)
FI (1) FI49504C (nl)
FR (1) FR2081498B1 (nl)
GB (1) GB1341109A (nl)
NL (1) NL170733C (nl)
SE (2) SE401674B (nl)
ZA (1) ZA71532B (nl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3896130A (en) * 1972-08-04 1975-07-22 Ayerst Mckenna & Harrison Ocathydrobenzocycloheptapyridoisoquinoline derivatives and process for the preparation thereof
US4053604A (en) * 1975-11-26 1977-10-11 Ayerst, Mckenna & Harrison Limited Method for improving anesthesia and compositions therefor
US4062851A (en) * 1975-11-26 1977-12-13 Ayerst Mckenna And Harrison Ltd. Process for the resolution of certain octahydrobenzocycloheptapyridoisoquinolinols
US4059585A (en) * 1976-07-27 1977-11-22 Ayerst Mckenna And Harrison Ltd. Process for preparing an intermediate for CNS depressants
FR2366839A2 (fr) * 1976-10-08 1978-05-05 Ayerst Mckenna & Harrison Derives de benzocycloheptane-isoquinoleine
TWI375676B (en) * 2005-08-29 2012-11-01 Msd Oss Bv Non-steroidal glucocorticoid receptor modulators
WO2017100623A1 (en) 2015-12-09 2017-06-15 Brandeis University Dbh inhibitors for treating or preventing memory loss
CN109970626A (zh) * 2018-12-30 2019-07-05 南京正荣医药化学有限公司 一种2-哌啶酮碱金属盐的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US336175A (en) * 1886-02-16 tompeins
US3052721A (en) * 1961-01-10 1962-09-04 Olin Mathieson Dihydrodibenzocy cloheptene derivatives
US3403157A (en) * 1965-09-01 1968-09-24 American Home Prod Benzo[6, 7]cyclohepta[1, 2, 3-d, e]isoquinoline derivatives

Also Published As

Publication number Publication date
AR206589A1 (es) 1976-08-06
FI49504B (nl) 1975-04-01
AR195768A1 (es) 1973-11-09
US3657250A (en) 1972-04-18
DE2106165A1 (de) 1971-08-19
SE406195B (sv) 1979-01-29
BE762595A (fr) 1971-08-05
CS181207B2 (en) 1978-03-31
FI49504C (fi) 1975-07-10
CH584201A5 (nl) 1977-01-31
ZA71532B (en) 1972-07-26
DK139582C (nl) 1979-09-03
CH569716A5 (nl) 1975-11-28
FR2081498A1 (nl) 1971-12-03
NL170733C (nl) 1982-12-16
CA982124A (en) 1976-01-20
NL7101752A (nl) 1971-08-12
AR195786A1 (es) 1973-11-09
FR2081498B1 (nl) 1975-01-17
DK139582B (da) 1979-03-12
NL170733B (nl) 1982-07-16
GB1341109A (en) 1973-12-19
CH548395A (fr) 1974-04-30
US3914305A (en) 1975-10-21
AR195785A1 (es) 1973-11-09

Similar Documents

Publication Publication Date Title
NO145883C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 7-methoxy-7-acylamino-cefalosporansyrederivater
SE393800B (sv) Forfarande for framstellning av bensoylamino-alkyl-fenoxi-alkylkarbonsyraderivat med lipidsenkande effekt
SE409460B (sv) Forfarande for framstellnoing av farmaceutiskt godtagbara syraadditionssalter av aminoglykosidantibiotika
NO143575C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive prostansyre-derivater
SE385885B (sv) Foerfarande foer framstaellning av 4-amino-6-arylpyrimidinderivat
SE405974B (sv) Forfarande for framstellning av 5,10-imino-dibenso(a,d)cykloheptenderivat samt syraadditionssalter derav
SE397677B (sv) Forfarande for framstellning av en alfa-dipeptidlagalkylester av l-asparaginsyra
SE385698B (sv) Forfarande for framstellning av kinolinettiksyraderivat
SE405477B (sv) Forfarande for framstellning av tetrazolyl-kinaldinsyraderivat med farmakologisk verkan
SE403911B (sv) Forfarande for framstellning av aroylsubstituerade fenylettiksyraderivat med anti-inflammatorisk verkan
SE401674B (sv) Forfarande for framstellning av farmakologiskt aktiva bensocykloheptaisokinolinderivat samt syraadditionssalter derav
SE400551B (sv) Forfarande for framstellning av terapeutiskt aktiva 3-amino-5-karbamylbensoesyraderivat
SE388199B (sv) Forfarande for framstellning av estrar av 3-metylflavon-8-karbonsyra med aminoalkoholer samt syraadditionssalter av dessa estrar
SE399708B (sv) Forfarande for framstellning av tioxanton-2-karboxylsyraderivat
SE380273B (sv) Forfarande for framstellning av tiopyrimidinderivat
SE393801B (sv) Forfarande for framstellning av tiokarbaminsyraderivat med antifungistatisk lekemedelsverken
SE385471B (sv) Forfarande for framstellning av bensobicykloalkanaminer med analgetisk eller anti-inflammatorisk lekemedelsverkan
NO139050C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive nororipavin- og tebainderivater
SE384852B (sv) Forfarande for framstellning av 2-(6-metoxi-2-naftyl) propionsyra
SE392611B (sv) Forfarande for framstellning av antrakinonkarboxylsyra
SE380517B (sv) Forfarande for framstellning av fluoren-2-ettiksyraderivat med antiinflammatorisk verkan
SE401829B (sv) Forfarande for framstellning av 5-fenyl-6,7-bensomorfanderivat och salter derav
SE388195B (sv) Forfarande for framstellning av 2,5-dihydroxibensensulfonsyraderivat med hemostatisk hypokolesterolemisk, hypotriglyceridemisk och hypolipemisk verkan
NO137998C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tebain- og oripavin-derivater
SE385887B (sv) Forfarande for framstellning av 5-substituerad-5-fenylalkylbarbitursyra med analgetisk verkan